These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 32925726

  • 1. Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission: A case report.
    Ishikawa Y, Kasuya T, Fujiwara M, Kita Y.
    Medicine (Baltimore); 2020 Sep 11; 99(37):e21943. PubMed ID: 32925726
    [Abstract] [Full Text] [Related]

  • 2. Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report.
    Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Hosono Y, Mimori T, Kawakami A.
    Medicine (Baltimore); 2018 Jun 11; 97(26):e11024. PubMed ID: 29952940
    [Abstract] [Full Text] [Related]

  • 3. Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Rapidly Progressing Interstitial Lung Disease Successfully Treated by Initiation of Combined Immunosuppressive Therapy Plus Plasma Exchange and Subsequently Switching Tacrolimus to Tofacitinib.
    Yamazoe M, Takeda K, Nagano Y, Nagano K, Kato K, Inoue T, Horiuchi K, Kamada K.
    Intern Med; 2024 Sep 15; 63(18):2571-2578. PubMed ID: 38346740
    [Abstract] [Full Text] [Related]

  • 4. Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis.
    Kurasawa K, Arai S, Namiki Y, Tanaka A, Takamura Y, Owada T, Arima M, Maezawa R.
    Rheumatology (Oxford); 2018 Dec 01; 57(12):2114-2119. PubMed ID: 30060040
    [Abstract] [Full Text] [Related]

  • 5. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
    Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, Okamoto Y, Hamaguchi Y, Murakami A, Hasegawa M, Kuwana M, Fujimoto M, Takehara K.
    Br J Dermatol; 2017 Feb 01; 176(2):395-402. PubMed ID: 27452897
    [Abstract] [Full Text] [Related]

  • 6. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.
    J Rheumatol; 2019 Aug 01; 46(8):935-942. PubMed ID: 31092718
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.
    Endo Y, Koga T, Suzuki T, Hara K, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Kawakami A.
    Medicine (Baltimore); 2018 Apr 01; 97(15):e0436. PubMed ID: 29642214
    [Abstract] [Full Text] [Related]

  • 8. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K, Yamaguchi A, Kashiwagi C, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Suzuki M, Kono S, Takemura M, Masubuchi H, Kitahara S, Hara K, Maeno T, Motegi SI, Muro Y, Sakairi T, Hisada T, Kurabayashi M.
    Respir Med; 2018 Jul 01; 140():1-5. PubMed ID: 29957268
    [Abstract] [Full Text] [Related]

  • 9. Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.
    Motegi SI, Sekiguchi A, Toki S, Kishi C, Endo Y, Yasuda M, Ikeuchi H, Sakairi T, Hara K, Yamaguchi K, Maeno T, Hiromura K, Ishikawa O.
    Eur J Dermatol; 2019 Oct 01; 29(5):511-517. PubMed ID: 31617496
    [Abstract] [Full Text] [Related]

  • 10. A case of clinically amyopathic dermatomyositis that was refractory to intensive immunosuppressive therapy including tofacitinib, but successfully treated with plasma exchange therapy.
    Hiraoka D, Ishizaki J, Horie K, Matsumoto T, Suemori K, Takenaka K, Hasegawa H.
    Mod Rheumatol Case Rep; 2022 Jun 24; 6(2):194-198. PubMed ID: 34984465
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment with tofacitinib for anti-melanoma differentiation-associated gene 5 antibody-positive juvenile dermatomyositis: case reports and review of the literature.
    Yamazaki S, Shimizu M, Yakabe A, Inage E, Jimbo K, Suzuki M, Miyaoka F, Kaneko S, Irabu H, Shimbo A, Ohtomo Y, Mori M, Morio T, Shimizu T.
    Immunol Med; 2024 Jun 24; 47(2):110-117. PubMed ID: 38557269
    [Abstract] [Full Text] [Related]

  • 12. Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease.
    Xu A, Ye Y, Fu Q, Lian X, Chen S, Guo Q, Lu LJ, Dai M, Lv X, Bao C.
    Rheumatology (Oxford); 2021 Jul 01; 60(7):3343-3351. PubMed ID: 33331866
    [Abstract] [Full Text] [Related]

  • 13. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
    Quintana-Ortega C, Remesal A, Ruiz de Valbuena M, de la Serna O, Laplaza-González M, Álvarez-Rojas E, Udaondo C, Alcobendas R, Murias S.
    Mod Rheumatol Case Rep; 2021 Jan 01; 5(1):101-107. PubMed ID: 33019894
    [Abstract] [Full Text] [Related]

  • 14. Successful treatment with tofacitinib for relapse of rapidly progressive interstitial lung disease in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis.
    Hama S, Akiyama M, Higashida-Konishi M, Oshige T, Takei H, Izumi K, Oshima H, Okano Y.
    Mod Rheumatol Case Rep; 2023 Jan 03; 7(1):92-95. PubMed ID: 35680682
    [Abstract] [Full Text] [Related]

  • 15. Noninvasive positive pressure ventilator deteriorates the outcome of pneumomediastinum in anti-MDA5 antibody-positive clinically amyopathic dermatomyositis.
    Zhou M, Ye Y, Yan N, Lian X, Bao C, Guo Q.
    Clin Rheumatol; 2020 Jun 03; 39(6):1919-1927. PubMed ID: 31942657
    [Abstract] [Full Text] [Related]

  • 16. Fatal and extensive multiorgan hemorrhages in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: An autopsy case report.
    Watanabe T, Takizawa N, Nagasaka T, Nakamura Y, Ikai H, Yamamoto M, Murai Y, Takasugi K, Yokoyama-Kokuryo W, Fujita Y.
    Medicine (Baltimore); 2020 Jan 03; 99(3):e18600. PubMed ID: 32011440
    [Abstract] [Full Text] [Related]

  • 17. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
    Ye Y, Fu Q, Wang R, Guo Q, Bao C.
    J Clin Lab Anal; 2019 Oct 03; 33(8):e22978. PubMed ID: 31301087
    [Abstract] [Full Text] [Related]

  • 18. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
    Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R.
    J Rheumatol; 2017 Mar 03; 44(3):319-325. PubMed ID: 28089977
    [Abstract] [Full Text] [Related]

  • 19. Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140/MDA5 antibody positive amyopathic dermatomyositis.
    Takada T, Aoki A, Asakawa K, Sakagami T, Moriyama H, Narita I, Sato S.
    Respir Med; 2015 Sep 03; 109(9):1174-80. PubMed ID: 26187000
    [Abstract] [Full Text] [Related]

  • 20. Early initiation of plasma exchange therapy for a patient with anti-MDA5 autoantibody-positive dermatomyositis developing rapidly progressive interstitial lung disease.
    Sasaki N, Ishii A, Kurabayashi T, Sugiyama M, Izumi Y, Nakagome Y, Hirano K, Sasaki S, Kondo Y, Nogi S, Nishikawa A, Hosono Y, Yamada C, Sato S.
    Mod Rheumatol Case Rep; 2021 Jan 03; 5(1):87-94. PubMed ID: 33048020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.